-
公开(公告)号:EP3389693A1
公开(公告)日:2018-10-24
申请号:EP16876883.6
申请日:2016-12-18
申请人: Agilvax, Inc.
CPC分类号: A61K39/0011 , A61K35/76 , A61K38/00 , A61K39/12 , A61K2039/5256 , A61K2039/5258 , A61K2039/572 , A61K2039/585 , A61K2039/812 , A61P35/00 , C12N15/62 , C12N15/86 , C12N2795/00023 , C12N2795/00034 , C12N2795/00041
摘要: Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.